Piperacillin and Tazobactam for injection: Particulate
Summary
See instructions below.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Teligent Canada |
Piperacillin and Tazobactam for injection 4.5g |
DIN 02401339 |
Powder for solution |
Piperacillin Sodium 4g, Tazobactam Sodium 0.5g |
305757. 305756 |
Teligent Canada |
Piperacillin and Tazobactam for injection 3.375g |
DIN 02401320 |
Powder for solution |
Piperacillin Sodium 3g, Tazobactam Sodium 0.375 g |
305664, 305665 |
Teligent Canada |
Piperacillin and Tazobactam for injection 2.25g |
DIN 02401312 |
Powder for solution |
Piperacillin Sodium 2g, Tazobactam Sodium 0.25g |
305666, 305718 |
Issue
Visible particles observed in vials following reconstitution
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Healthcare Establishments
Details
|
Teligent Canada Inc. 5995 Avebury Road, Suite 804, Mississauga, Ontario L5R 3P9 |
Get notified
Receive notifications for new and updated recalls and alerts by category.